Faculty Descriptions and Representative Publications

Faculty: Patricia Areán, Ph.D.
Patricia Areán, Ph.D. is an Associate Professor in the Department of Psychiatry. Dr. Areán is a Clinical Psychologist, health services researcher, and an internationally recognized expert in effectiveness of psychotherapy for the treatment of mental disorders in older adults and minorities. She is a member of the NIMH study section for services research in specialty settings. Her research is funded by NIMH, Hartford Foundation, California Health Care Foundation, NIA and SAMHSA and includes treatment effectiveness, access research on mental health and substance abuse in older and minority populations. The fellows she has mentored have largely gone on to academic positions.

Areán PA, Ayalon L, Hunkeler EM, Tang L, Unutzer J, Lin E, Harpole L, Williams J, Hendrie H. (2005). Improving depression care in older, minority primary care patients. Medical Care, 43(4), 381-390.

Areán PA, Reynolds CF III. (2005). Psychosocial risk factors in late life depression. Biological Psychiatry, 58: 277-282.

Feldman MD, Arean PA, Ong MK, Lee DL, Feldman S. (2005). Creating incentives for primary care providers to refer patients to a collaborative care program for depression. Psychiatric Services, 56(11), 1- 3.

Hegel MT, Unutzer J, Tang L, Areán PA, Katon W, Noel PH, Williams JW, Lin EH. (2005). Impact of comorbid panic and post traumatic stress disorder on outcomes of collaborative care for late-life depression in primary care. American Journal of Geriatric Psychiatry, 13(1), 48-58.

Satre D, Areán PA. (2005). Effects of gender, ethnicity, and medical illness on drinking cessation in older primary care patients. Journal of Aging and Health, 17(1), 71-84.


Faculty: Timothy Carmody, Ph.D.
Timothy Carmody, Ph.D. is a Clinical Professor in the Department of Psychiatry, University of California, San Francisco, Director of the Health Psychology Program, and Director of Primary Care Psychology Training Programs at the San Francisco Veterans Affairs Medical Center. Dr. Carmody received his doctorate in clinical psychology from the University of Montana in 1977. For eight years, he was a faculty member in the Department of Medical Psychology at the Oregon Health Sciences University. His primary research interests include smoking cessation, pain management, behavioral factors in coronary disease prevention, and obesity/weight control. His research has been funded through the VA Health Services Research and Development Program and University of California Tobacco-Related Disease Research Program (TRDRP) for conducting clinical trials in smoking cessation. He is active as a teacher and mentor in the SFVAMC pre-doctoral APA-approved clinical internship training program. He serves as a consultant to the VA’s Office of Research and Cooperative Studies Program and is a member of the VA Smoking Cessation Technical Advisory Group for the Public Health and Prevention Office at VA Headquarters. He has been the recipient of a Research Career Development Award from the National Heart Lung and Blood Institute (NHLBI) and has served on several ad hoc grant review committees for NHLBI. He serves on the editorial board of the Journal of Clinical Psychology in Medical Settings and is an editorial consultant to several other professional journals. He is currently a TRC component PI for a clinical trial investigating an intensive smoking cessation intervention for alcohol-dependent smokers in early recovery. Trainees working with Dr. Carmody have an opportunity to participate in secondary data analysis projects examining research questions related to smoking cessation treatment and assist the Smoking Cessation Research Group at the SFVAMC with data management and data collection activities related to ongoing clinical trials.

Key words: tobacco use disorder, chronic pain, cognitive behavior therapy, obesity/weight control

Tong EK, Carmody TP, & Simon JA. (2006) Bupropion for smoking cessation: A review. Comprehensive Therapy, 32(1), 26-33.

Simon JA, Duncan C, Carmody TP, & Hudes ES. (2004). Bupropion for smoking cessation: A randomized trial. Archives of Internal Medicine, 164(16), 1797-1803.

Simon JA, Carmody TP, Hudes ES, Snyder E, & Murray J. (2003). Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers on transdermal nicotine replacement: A randomized trial. American Journal of Medicine, 114(7), 555-562.

Carmody TP. (2002). Smoking cessation treatment groups. In R. Brook & H. Spitz (Eds.), Group Psychotherapy for Substance Abuse, American Psychiatric Association.

Carmody TP. (2001). Psychosocial subgroups, coping, and chronic low back pain. Journal of Clinical Psychology in Medical Settings, 8, 137-148.

Faculty: Gary Humfleet, Ph.D.
Gary Humfleet, Ph.D. is an Associate Clinical Professor and the Clinical Director of the Habit Abatement Clinic, where we conduct randomized clinical trials to evaluate the efficacy of innovative smoking cessation treatments. Dr. Humfleet’s research focuses on the efficacy of clinical interventions for nicotine dependence, factors predictive of smoking treatment success, and development of Internet-based interventions for nicotine dependence and factors predictive of smoking treatment success. His research interests include evaluating innovative behavioral and pharmacological treatment models, expanding modes of treatment delivery to incorporate technology-based intervention, and integrating evidence-based treatments into various clinical/community settings. Within this context, his work also focuses on addressing health disparities by targeting population groups who are at increased risk for tobacco use and dependence and have less access to smoking treatment services. He has recently completed a clinical trial evaluating the efficacy of Internet-based smoking treatment for lesbian, gay, bisexual, and transgender (LGBT) cigarette smokers and is currently conducting a study comparing technology-based treatments, internet and telephone, with the same population. As a part of the UCSF Treatment Research Center, Dr. Humfleet leads a study evaluating the efficacy and cost-effectiveness of smoking treatment provided in HIV clinical care settings. Other work has focused on the efficacy of mood management techniques in smoking treatment and the development of smoking treatment based on a conceptualization of nicotine dependence as a chronic, relapsing disorder. He is also interested in the impact of alcohol and drug use on smoking cessation outcomes. As a faculty member, he works closely with scholars interested in nicotine dependence, serves as a mentor to postdoctoral fellows, and co-teaches the Substance Abuse Seminar and Lecture Series each year.

Key words: smoking, nicotine dependence, gay, lesbian, bisexual, transgender, HIV, computer, Internet, special populations, clinical trials, health disparities

Humfleet GL, Hall SM, Delucchi K & Dilley J. (In Press).  Baseline characteristics of HIV-positive cigarette smokers entering smoking treatment:  Implications for future research and treatment.  AIDS Education and Prevention.

 

Lawhon D, Humfleet G, & Hall SM. (In Press).  Longitudinal Analysis of Abstinence-Specific social support and smoking cessation.  Health Psychology.

 

Hall SM, Humfleet GL, Reus VI, Muñoz RF & Forecki J. (2009) Extended treatment of older cigarette smokers.  Addiction, 104(6), 1043-52.

 

Humfleet G, Prochaska J, Mengis M, Cullen J, Muñoz R, Reus V, & Hall S. (2005). Preliminary evidence of the association between the history of childhood attention deficit hyperactivity disorder and smoking treatment failure. Nicotine and Tobacco Research, 7(3), 453-460.

Humfleet GL & Haas AL. (2004). Is marijuana use becoming a “gateway” to nicotine dependence? Addiction, 99(1), 5-6.

Faculty: Carol A. Matthews, M.D.
Carol A. Mathews, M.D., is an Associate Professor in the Department of Psychiatry. Her research focuses on the phenomenology, epidemiology, and genetics of neuropsychiatric symptoms and disorders, including obsessive-compulsive disorder (OCD), Tourette Syndrome (TS) and attention deficit hyperactivity disorder (ADHD). Her research is funded by NINDS, NIMH, NARSAD, the Obsessive Compulsive Foundation, and the Tourette Syndrome Association, and includes genetic studies of OCD, TS, and ADHD in Costa Rica and the US, studies of potential environmental factors that predispose or worsen neuropsychiatric symptoms (including prenatal maternal nicotine, drug, and alcohol use) and epidemiological studies of neuropsychiatric symptoms in non-clinical populations and relatives of individuals with neuropsychiatric disorders. She is also interested in the comorbidity and common etiological factors underlying anxiety disorders and substance abuse. Research opportunities in her lab include translational research into comorbid substance use and anxiety and impulse control disorders, including, but not limited to, genetic and epidemiological studies, and studies of environmental risk factors predisposing to these disorders.

Mathews CA, Bimson B, Lowe TL, Herrera LD, Budman CL, Erenberg G, Naarden A, Bruun RD, Freimer NB, Reus VI (2006). Association between maternal smoking and increased symptom severity in Tourette Syndrome. American Journal of Psychiatry, 163(6), 1066-1073.

Abelson JF, Kwan KY, O'roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LS 4th, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW (2005). Sequence variants in SLITRK1 are associated with Tourette's Syndrome. Science, 310(5746), 317-320.

Mathews CA, Jang K, Hami S, Stein MB (2004). The structure of obsessionality in young adults. Depression and Anxiety, 20(2), 77-85.

Mathews CA, Reus VI, Bejarano J, Escamilla ME, Fournier E, Herrera LD, Lowe TL, McInnes LA, Molina J, Ophoff RA, Raventos H, Sandkuijl LA, Service SK, Spesny S, León PE, Freimer NB (2004). Genetic studies of neuropsychiatric disorders in central america. Psychiatric Genetics, 14(1), 13-23.

Escamilla MA, Batki SL, Reus VI, Spesny M, Molina J, Service S, Vinogradov S, Neylan T, Mathews C, Meza L, Gallegos A, Montero AP, Cruz ML, Neuhaus J, Roche E, Smith L, Leon P, Freimer NB. (2002). Comorbidity of bipolar disorder and substance abuse in a Latin American population: Pedigree and population based studies. Journal of Affective Disorders, 71:71-83.


Faculty: Ricardo Muñoz, Ph.D.
Ricardo Muñoz, Ph.D. is Professor of Psychology in the Department of Psychiatry where he serves as Director of the Clinical Psychology Training Program, Chief Psychologist at San Francisco General Hospital (SFGH), and Director of the UCSF/SFGH Latino Mental Health Research Program. His research program is focused on the development and evaluation of methods to screen for, prevent, and treat major depression. He uses a social learning orientation and cognitive-behavioral self-control approaches, and includes Spanish- and English-speaking populations in his work. He was the founding Director of the SFGH Depression Clinic. He has published over 60 articles and chapters, and co-authored or edited five books. His current project is the “Internet Health Research Center: Smoking, Latinos, & the Web,” a bilingual site using randomized control trial methodology conducted via the World Wide Web which tests various smoking cessation approaches. Dr. Munoz welcomes bilingual and biliterate Spanish-speaking postdoctoral trainees with cognitive-behavioral intervention expertise in smoking, depression, or ideally, both. Preferred additional skills include randomized trial methodology, internet-based research, good data analytical ability, and strong interest in reaching underserved populations worldwide with smoking cessation interventions. See http://www.apa.org/monitor/feb02/reaching.html for more information about Dr. Munoz’s laboratory.

Key words: Spanish-speaking, Latinos, depression, smoking, internet research
 

Muñoz RF, Barrera AZ, Delucchi K, Penilla C, Torres LD, Pérez-Stable EJ. (In Press). International Spanish/English Internet Smoking Cessation Trial Yields 20% Abstinence Rates at One Year. Nicotine and Tobacco Research.

 

Leykin Y, Barrera AZ, Muñoz RF (In Press)  Using the Internet to Provide Smoking Cessation Interventions Worldwide.  In M.A. Cucciare & K. R. Weingardt (Eds.)  Using Technology to support Evidence-Based Behavioral Health Practices:  A Clinician's Guide.

 

Torres LD, Barrera AZ, Delucchi K, Penilla C, Pérez-Stable EJ, Muñoz RF.  (In Press)  Quitting smoking does not increase the risk of major depressive episodes among users of Internet smoking cessation interventions.  Psychological Medicine.

 

Barrera AZ, Pérez-Stable EJ, Delucchi K, & Muñoz RG. (2009).  Global reach of an Internet smoking cessation intervention among Spanish and English Speaking smokers from 157 countries.  International Journal of Environmental Research and Public Health, 6(3), 927-940.

 

Muñoz RF, Lenert LL, Delucchi K, Stoddard J, Pérez EJ, Penilla C, Pérez-Stable EJ. (2006). Toward evidence-based Internet interventions: A Spanish/English Web site for international smoking cessation trials. Nicotine & Tobacco Research, 8(1), 77-87.

Muñoz RF & Mendelson T (2005). Toward evidence-based interventions for diverse populations: The San Francisco General Hospital prevention and treatment manuals. Journal of Consulting and Clinical Psychology, 73(5), 790-799.


Faculty: Judith Prochaska, Ph.D., M.P.H.
Judith Prochaska, Ph.D., M.P.H. is an Associate Professor in Residence in the UCSF Department of Psychiatry. Her research focuses on developing effective treatments for tobacco dependence and other leading health risk factors with a specific focus on populations with co-occurring disorders. Current studies include: (1) a NIDA-funded K23 career development award to evaluate extended treatment for tobacco dependence initiated in an inpatient psychiatric setting; (2) a TRDRP-funded study to develop and evaluate a tobacco cessation curriculum for psychiatry residency training programs; (3) a NIDA-funded Clinical trial evaluating a tobacoo cessation intervention for adolescents and young adults recruited from outpaitent mental health settings.  The interventions are comprehensive combining motivational and cognitive behavioral approaches with pharmacotherapy.  Another line of research interest for Dr. Prochaska focuses on interventions addressing multiple risk behaviors.

Key words: comorbidity, tobacco, nicotine, treatment, mentally ill, multiple behavioral risks

Nides M, Glover ED, Reus VI, Christen AG, Make BJ, Billling CB Jr, Williams KE. (2008). Varenicline versus bupropion SR or placebo for smoking cessation:  a pooled analyse. American Journal of Health Behaviors. 32(6), 664-75.

 

Mooney ME, Reus VI, Gorecki J, Hall SM, Humfleet GL, Munoz RF, Delucchi K.  (2008). Therapeutic drug monitoring of nortirptyline in smoking cessation:  a multistudy annalysis. (2008) Clinical Pharmaclogy Therapeutics, 83(3), 436-42.

 

Reus VI, Obach RS, Coe JW, Faessel H, Rollema H, Watshky E, Reeves K, (2007). Varenicline:  new treatment with efficacy in smoking cessation.  Drugs Today, 43(2), 65-75.

Harris DS, Reus VI, Wolkowitz O, Jacob P 3rd, Everhart ET, Wilson M, Mendelson JE, Jones RT (2006). Catecholamine response to methamphetamine is related to glucocorticoid levels but not to pleasurable subjective response. Pharmacopsychiatry, 39(3), 100-8.

Faculty: Derek Satre, Ph.D.
Derek Satre, Ph.D. is an Assistant Adjunct Professor in the UCSF Department of Psychiatry. Dr. Satre’s research is primarily focused on addiction and mental health services. He works closely with the Drug and Alcohol Research Team at the Kaiser Division of Research, directed by Dr. Constance Weisner. In collaboration with this research team, he has investigated age differences in outcomes of patients in the Kaiser Permanente chemical dependency recovery programs, including studies of gender differences and long-term treatment outcomes. He is currently developing a treatment program for older adults in outpatient chemical dependency treatment at Kaiser Permanente, funded by a K23 Career Development Award from NIAAA. He is also interested in treatment for individuals with comorbid chemical dependency and mood disorders, and is involved in a study screening for alcohol and drug problems among psychiatric outpatients at UCSF. Dr. Satre works closely with Dr. Connie Weisner and is open to serving as a co-mentor to postdoctoral fellows.

Satre DD, Kohn C & Weisner C. (2007). Cigarette smoking and long term alcohol and drug treatment outcomes: A telephone follow-up at 5 years. The American Journal on Addictions, 16(1), 32-37.

Satre DD, Knight BG & David S. (2006). Cognitive behavioral interventions with older adults: Integrating clinical and gerontological research. Professional Psychology: Research and Practice, 37, 489-498.                                                                                                                                                                           Satre D D & Areán PA. (2005).  Effects of gender, ethnicity, and medical illness on drinking cessation in older primary care patients.  Journal of Aging and Health, 17(1), 70-84.

Satre DD, Mertens JR, Areán PA & Weisner C. (2004). Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program. Addiction, 99(10), 1286-1297.

Faculty: Janice Tsoh, Ph.D.
Janice Tsoh, Ph.D. is an Assistant Adjunct Professor in the Department of Psychiatry. She is a clinical psychologist specialized in behavioral medicine and health psychology. Dr. Tsoh is a Principal Investigator on three studies: "Expert System and Family Assisted Interventions for Chinese Smokers" funded by the American Cancer Society, a development trial examining a stepped-care smoking model for patients in substance abuse outpatient treatment setting funded by NIDA, and "A Stage-Matched Scheduled Smoking Intervention for Chinese" funded by the California Tobaccor Related Disease Research Program. Her research program focus on nicotine dependence and smoking cessation treatment in special populations: 1) researching effective channels for delivering smoking cessation treatment; 2) developing comprehensive and cultural sensitive treatment approaches using a combination of pharmacological and psychological interventions; and 3) disseminating intervention technology from research to the community.

Key words: nicotine dependence, smoking cessation, health promotion, disease prevention, cancer prevention, health disparities, depression, substance abuse, cross-cultural psychology, minority health

Schmitt EM, Tsoh JY, Dowling GA, Hall SM. (2005). Older adults' and case managers' perceptions of smoking and smoking cessation. Journal of Aging and Health, 17(6), 717-33.

Tsoh JY & Hall SM. (2004). Depression and smoking: from the Transtheoretical Model of change perspective. Addictive Behaviors, 29(4), 801-805.

Tsoh JY, Lam JN, Delucchi K, & Hall SM. (2003). Smoking and depression in Chinese Americans. The American Journal of Medical Sciences, 326(4), 187-191.

Kohn CS, Tsoh JY, & Weisner CM. (2003). Changes in smoking status among substance abusers: baseline characteristics and association with treatment outcomes at 12-months. Drug and Alcohol Dependence, 69(1), 61-71.

Prochaska JO, Velicer WF, Fava JL, Rossi JS, & Tsoh JY. (2001). Evaluation a population based recruitment approache and a stage-matched expert system for smoking cessation. Addictive Behaviors. 26I (4), 583-602.